Dr Richard Hubner, Consultant Medical Oncologist
Dr Richard Hubner
Consultant Medical Oncologist
Dr Hubner is a Consultant Medical Oncologist
Areas of expertise
- Chemotherapy
- Gallbladder cancer
- Pancreas and bile duct cancers
- Teenage & young adult cancers
- Neuroendocrine cancers
Make an appointment
Address
-
The Christie Private Care
Wilmslow Road, Manchester, M20 4BX
About Dr Richard Hubner
GMC number: 4530419
Year qualified: 1998
Place of primary qualification: Oxford University
Areas of expertise
- Upper gastrointestinal
- Hepatopancreatobiliary cancer
- Cancer oesophagus
- Stomach
- Pancreas
- Bile duct
- Gallbladder
- Liver
- Neuroendocrine system
Professional memberships
Articles by Dr Richard Hubner
add-aspirin trial: a phase iii, double blind, placebo-controlled, randomized trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common nonmetastatic solid tumors
Phase ii study of the antibody-drug conjugate tak-264 (mln0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase c
A phase ii study of antibody-drug conjugate, tak-264 (mln0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase c
Targeting the epidermal growth factor receptor in addition to chemotherapy in patients with advanced pancreatic cancer: a systematic review and meta-analysis
Abstract 3960: combined circulating tumour cell (ctc) and circulating tumor dna (ctdna) analysis of blood from patients with pancreatic cancer
Adi-peg 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
Aspirin as an adjuvant treatment for cancer: feasibility results from the add-aspirin randomised trial
